Charité Universitätsmedizin Berlin, Klinik für Neonatologie
Berlin, 13353, Germany
NCT Number: NCT07411872
In very low birth weight (<1500g) preterm infants, nutrition with mother's own milk, as opposed to formula, is associated with reduced morbidity and mortality. At present, the merits and risks of pasteurising mother's own milk (recommended if the mother is positive for cytomegalovirus) are unknown. This single-institution retrospective analysis aims at comparing mortality and morbidity of preterm infants below 1500g birth weight who were fed raw (unpasteurized) or pasteurized mother's own milk (in case the mother is positive for cytomegalovirus). The infant's sex into is taken into account as a possible confounder.
Looking for future studies?
Notify MeAll sexes
Observational
Berlin, 13353, Germany
Retrospective analysis of preterm infants below 1500g birth admitted 2019-2024 to the Department of Neonatology at the Charité - Universitätsmedizin Berlin. Infants with major congenital malformation, chromosomal aberrrations and known genetic conditions are excluded. Input variables are basic demographic data (gestational age, birth weight, sex, antenatal steroids, and others), duration of mother's own milk feeding, duration of donor milk feeding, cytomegalovirus status of the mother, pasteurization of mother's own milk (start and end date), main outcome variables are death, major surgery, necrotizing enterocolitis, duration of antibiotic treatment, duration of positive pressure ventilation, duration of oxygen supplementation, duration of hospital treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Major congenital malformations Chromosomal aberrations Known genetic conditions
Time frame: up to 24 weeks or discharge from hospital, whatever occurs first
Necrotizing enterocolitis (requiring surgery), sepsis (blood culture-positive), bronchopulmonary dysplasia (requirement for oxygen supplementration at 36 weeks postmenstrual age), severe retinopathy (grade 3 or treatment with laser or intravitreal anti-VEGF agents)
Time frame: up to 24 weeks or discharge from hospital, whatever occurs first
interval between date of birth and date of elective cessation of measure
Charite University, Berlin, Germany
Other
Einfluss Von Geschlecht Und Pasteurisierung Auf Das Neonatale Outcome Bei Frühgeborenen Unter 1.500 g: Retrospektive Analyse Zur Bedeutung Der Muttermilch
Acronym: G-PAMINEO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07577180
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD)
Köseköy, Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT00593684
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Dallas, Texas, United States
View Trial DetailsNCT07689669
Apnea, Apnea of Prematurity
Konya, Turkey (Türkiye)
View Trial DetailsNCT07622459
Female Urogenital Diseases and Pregnancy Complications, Mechanical Ventilation
Sanliurfa, Turkey (Türkiye)
View Trial Details